inflammatory bowel disease
inflammatory bowel disease
12/30/2022
Jean-Frederic Colombel, MD, from Mount Sinai, answers our questions about how the management of inflammatory bowel disease has evolved over time.
12/30/2022
Expert Q&A
Expert Q&A
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
Expert Q&A
Expert Q&A
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
Expert Q&A
Expert Q&A
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
Expert Q&A
Expert Q&A
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
Expert Q&A
Expert Q&A
12/09/2022
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
12/09/2022
hearing loss
hearing loss
11/28/2022
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
11/28/2022
hearing loss
hearing loss
11/28/2022
In this Q and A, Rebecca Sherman, AuD, answers our questions on the importance of monitoring hearing as a patient gets older, how hearing loss affects the brain, and the link between untreated hearing loss...
11/28/2022
Expert Q&A
Expert Q&A
11/21/2022
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
11/21/2022
Expert Q&A
Expert Q&A
11/21/2022
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
11/21/2022